Chris Martin

CEO at ADC Therapeutics - New Providence, NJ, US

Chris Martin's Colleagues at ADC Therapeutics
Kirk Hayenga

Head of Manufacturing Technical Operations

Contact Kirk Hayenga

Liangyi Zhang

Director of Analytical Development

Contact Liangyi Zhang

Thor Grespan

Director, Quality Assurance

Contact Thor Grespan

Hirak Desai

Associate Director - Upstream Development and Manufacturing

Contact Hirak Desai

Corey White

Hematology Therapeutic Specialist

Contact Corey White

View All Chris Martin's Colleagues
Chris Martin's Contact Details
HQ
908-731-5556
Location
Company
ADC Therapeutics
Chris Martin's Company Details
ADC Therapeutics logo, ADC Therapeutics contact details

ADC Therapeutics

New Providence, NJ, US • 250 - 499 Employees
BioTech/Drugs

ADC Therapeutics is a clinical-stage oncology biotechnology company leading the development and commercialization of next-generation antibody drug conjugates (ADCs) with highly potent and targeted pyrrolobenzodiazepine (PBD) dimer technology.  These proprietary PBD-based ADCs are expected to provide a novel way to treat hematological cancers and solid tumors, address significant unmet medical needs, and improve the lives of patients with cancer. Our mission is to confront cancer with the full potential of our science to bring unique, targeted therapies and hope to patients and their families.

N/A
Details about ADC Therapeutics
Frequently Asked Questions about Chris Martin
Chris Martin currently works for ADC Therapeutics.
Chris Martin's role at ADC Therapeutics is CEO.
Chris Martin's email address is ***@myricxbio.com. To view Chris Martin's full email address, please signup to ConnectPlex.
Chris Martin works in the Biotechnology industry.
Chris Martin's colleagues at ADC Therapeutics are Kirk Hayenga, David Pritchett, Liangyi Zhang, Thor Grespan, Hirak Desai, Susan Garnick, Corey White and others.
Chris Martin's phone number is 908-731-5556
See more information about Chris Martin